GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (LTS:0JW9) » Definitions » Change In Prepaid Assets

MEI Pharma (LTS:0JW9) Change In Prepaid Assets : $6.25 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is MEI Pharma Change In Prepaid Assets?

MEI Pharma's Change In Prepaid Assets for the quarter that ended in Dec. 2024 was $0.19 Mil. It means MEI Pharma's Prepaid Assets increased by $0.19 Mil from Sep. 2024 to Dec. 2024 .

MEI Pharma's Change In Prepaid Assets for the fiscal year that ended in Jun. 2024 was $4.53 Mil. It means MEI Pharma's Prepaid Assets increased by $4.53 Mil from Jun. 2023 to Jun. 2024 .

MEI Pharma Change In Prepaid Assets Historical Data

The historical data trend for MEI Pharma's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEI Pharma Change In Prepaid Assets Chart

MEI Pharma Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.81 -1.07 -0.02 -2.92 4.53

MEI Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.47 4.09 0.39 1.58 0.19

MEI Pharma Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEI Pharma Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of MEI Pharma's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

MEI Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (LTS:0JW9) » Definitions » Change In Prepaid Assets
Comparable Companies
PRTG CLRB SYBX BIXT PLRZ GOVX KAPA ERNA PSTV MRKR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
MEIP:USA
Address
9920 Pacific Heights Blvd, Suite 150, San Diego, CA, USA, 92121
Website
https://www.meipharma.com
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

MEI Pharma Headlines

No Headlines